NO160205C - Fremgangsmaate ved fremstilling av silibininderivater. - Google Patents

Fremgangsmaate ved fremstilling av silibininderivater.

Info

Publication number
NO160205C
NO160205C NO854655A NO854655A NO160205C NO 160205 C NO160205 C NO 160205C NO 854655 A NO854655 A NO 854655A NO 854655 A NO854655 A NO 854655A NO 160205 C NO160205 C NO 160205C
Authority
NO
Norway
Prior art keywords
silibine
ingredients
procedure
preparation
silibine ingredients
Prior art date
Application number
NO854655A
Other languages
English (en)
Norwegian (no)
Other versions
NO854655L (no
NO160205B (no
Inventor
Reinhard Braatz
Klaus Goerler
Guenter Halbach
Hartwig Soicke
Karlheinz Schmidt
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of NO854655L publication Critical patent/NO854655L/no
Publication of NO160205B publication Critical patent/NO160205B/no
Publication of NO160205C publication Critical patent/NO160205C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
NO854655A 1984-11-22 1985-11-21 Fremgangsmaate ved fremstilling av silibininderivater. NO160205C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (3)

Publication Number Publication Date
NO854655L NO854655L (no) 1986-05-23
NO160205B NO160205B (no) 1988-12-12
NO160205C true NO160205C (no) 1989-03-22

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
NO854655A NO160205C (no) 1984-11-22 1985-11-21 Fremgangsmaate ved fremstilling av silibininderivater.

Country Status (29)

Country Link
JP (1) JPS61143377A (fi)
KR (1) KR870001020B1 (fi)
AR (1) AR240931A1 (fi)
AT (1) AT393268B (fi)
BE (1) BE903693A (fi)
CA (1) CA1337124C (fi)
CH (1) CH659473A5 (fi)
CS (1) CS273610B2 (fi)
DD (1) DD259191A1 (fi)
DE (1) DE3442639A1 (fi)
DK (1) DK164865C (fi)
EG (1) EG19424A (fi)
ES (1) ES8609311A1 (fi)
FI (1) FI84064C (fi)
FR (1) FR2573427B1 (fi)
GB (1) GB2167414B (fi)
HU (1) HU195503B (fi)
IE (1) IE58791B1 (fi)
IT (1) IT1190426B (fi)
LU (1) LU86163A1 (fi)
MX (1) MX168415B (fi)
NL (1) NL192387C (fi)
NO (1) NO160205C (fi)
PL (1) PL146890B1 (fi)
PT (1) PT81532B (fi)
SE (1) SE465676B (fi)
SU (1) SU1436875A3 (fi)
YU (1) YU43689B (fi)
ZA (1) ZA858951B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
AU2006222556B2 (en) * 2005-03-11 2011-09-29 Armaron Bio Pty Ltd Flavonoid compounds and uses thereof
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
PL2219642T3 (pl) * 2007-11-15 2012-02-29 Madaus Gmbh Komponent sylibininy do leczenia zapalenia wątroby
TWI529167B (zh) * 2009-05-14 2016-04-11 歐羅梅德股份有限公司 用於治療病毒性肝炎之非晶型水飛薊賓
PL3409280T3 (pl) 2012-07-05 2021-10-18 Nutramax Laboratories, Inc. Kompozycje zawierające sulforafan i wyciąg lub proszek z ostropestu plamistego
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
IE58791B1 (en) 1993-11-17
CH659473A5 (de) 1987-01-30
NO854655L (no) 1986-05-23
NL192387B (nl) 1997-03-03
FR2573427B1 (fr) 1989-03-10
LU86163A1 (de) 1986-03-24
CA1337124C (en) 1995-09-26
AR240931A2 (es) 1991-03-27
DK164865C (da) 1993-01-18
FI84064C (fi) 1991-10-10
AR240931A1 (es) 1991-03-27
FR2573427A1 (fr) 1986-05-23
KR860004056A (ko) 1986-06-16
SE8505487D0 (sv) 1985-11-20
FI84064B (fi) 1991-06-28
NL8503171A (nl) 1986-06-16
CS837885A2 (en) 1990-08-14
NO160205B (no) 1988-12-12
KR870001020B1 (ko) 1987-05-23
YU178685A (en) 1988-02-29
EG19424A (en) 1995-02-28
JPH0432073B2 (fi) 1992-05-28
IT1190426B (it) 1988-02-16
FI854535A (fi) 1986-05-23
ATA337185A (de) 1991-02-15
HU195503B (en) 1988-05-30
AT393268B (de) 1991-09-25
ES549116A0 (es) 1986-09-01
DD259191A1 (de) 1988-08-17
PT81532B (pt) 1987-11-11
MX168415B (es) 1993-05-24
BE903693A (fr) 1986-05-22
SU1436875A3 (ru) 1988-11-07
CS273610B2 (en) 1991-03-12
PT81532A (de) 1985-12-01
SE8505487L (sv) 1986-05-23
YU43689B (en) 1989-10-31
GB2167414A (en) 1986-05-29
DE3442639C2 (fi) 1989-08-10
FI854535A0 (fi) 1985-11-18
NL192387C (nl) 1997-07-04
GB2167414B (en) 1989-01-11
DK537785A (da) 1986-05-23
ES8609311A1 (es) 1986-09-01
PL256374A1 (en) 1986-12-02
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
HUT40114A (en) 1986-11-28
DE3442639A1 (de) 1986-05-22
DK537785D0 (da) 1985-11-21
JPS61143377A (ja) 1986-07-01
GB8528226D0 (en) 1985-12-18
ZA858951B (en) 1986-08-27
IT8522932A0 (it) 1985-11-21
DK164865B (da) 1992-08-31
IE852808L (en) 1986-05-22

Similar Documents

Publication Publication Date Title
NO852124L (no) Fremgangsmaate ved fremstilling av kinolonderivater.
NO851400L (no) Fremgangsmaate ved fremstilling av fysiologisk aktive polypeptider.
NO852994L (no) Fremgangsmaate ved fremstilling av glutaramidderivater.
NO167515C (no) Fremgangsmaate for fremstilling av basissmoereoljer.
NO170071C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO165755C (no) Fremgangsmaate ved fremstilling av tetrafluorbenzosyre.
NO160206C (no) Fremgangsmaate ved fremstilling av isosilybinfri silibinin.
NO884665L (no) Fremgangsmaate ved fremstilling av 9-oh-alkoksyguanin.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO160205C (no) Fremgangsmaate ved fremstilling av silibininderivater.
NO165676C (no) Fremgangsmaate ved fremstilling av pyrrolidonderivater.
NO852810L (no) Fremgangsmaate ved fremstilling av fluorallylaminderivater.
NO853066L (no) Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO860794L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO853172L (no) Fremgangsmaate for fremstilling av tixotrope vaskemidler.
NO872809L (no) FremgangsmŸte ved fremstilling av 5-amino-alicylsyre.
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
NO872094D0 (no) Fremgangsmaate ved fremstilling av dbh-inhiberende forbindelser.
NO165538C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO864386D0 (no) Fremgangsmaate ved fremstilling av uretaner.
NO161353C (no) Fremgangsmaate for fremstilling av pastiller.
NO870543L (no) Fremgangsmaate ved fremstilling av 4-acetylisokinolinonforbindelser.
NO161911C (no) Fremgangsmaate for fremstilling av sulfonater.
NO166709C (no) Fremgangsmaate for fremstilling av akrylamider.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2002